{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:26:33Z","timestamp":1784258793288,"version":"3.55.0"},"reference-count":57,"publisher":"Impact Journals, LLC","issue":"31","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,8,2]]},"DOI":"10.18632\/oncotarget.10418","type":"journal-article","created":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T14:28:29Z","timestamp":1467815309000},"page":"49623-49635","source":"Crossref","is-referenced-by-count":53,"title":["In-depth proteomic profiling of the uveal melanoma secretome"],"prefix":"10.18632","volume":"7","author":[{"given":"Martina","family":"Angi","sequence":"first","affiliation":[{"name":"Liverpool Ocular Oncology Research Group, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Kalirai","sequence":"additional","affiliation":[{"name":"Liverpool Ocular Oncology Research Group, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Prendergast","sequence":"additional","affiliation":[{"name":"Liverpool Ocular Oncology Research Group, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Simpson","sequence":"additional","affiliation":[{"name":"Centre for Proteome Research, Institute of Integrative Biology, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean E.","family":"Hammond","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele C.","family":"Madigan","sequence":"additional","affiliation":[{"name":"School of Optometry, University of New South Wales, New South Wales, Australia"},{"name":"Save Sight Institute, Ophthalmology, University of Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Beynon","sequence":"additional","affiliation":[{"name":"Centre for Proteome Research, Institute of Integrative Biology, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Coupland","sequence":"additional","affiliation":[{"name":"Liverpool Ocular Oncology Research Group, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,7,6]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0161-6420(03)00078-2","article-title":"Incidence of uveal melanoma in the United States: 1973-1997","volume":"110","author":"Topham","year":"2003","journal-title":"Ophthalmology"},{"key":"2","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.hoc.2012.08.004","article-title":"Epidemiology and management of uveal melanoma","volume":"26","author":"Kim","year":"2012","journal-title":"Hematol Oncol Clin North Am"},{"key":"3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/sj.bjc.6605765","article-title":"Does ocular treatment of uveal melanoma influence survival?","volume":"103","author":"Damato","year":"2010","journal-title":"Br J Cancer"},{"key":"4","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/archopht.123.12.1639","article-title":"Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26","volume":"123","author":"Robertson","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/ICU.0000000000000051","article-title":"Recent developments in prognostic and predictive testing in uveal melanoma","volume":"25","author":"Harbour","year":"2014","journal-title":"Curr Opin Ophthalmol"},{"key":"6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/eye.2012.256","article-title":"Prognostication in eye cancer: the latest tumor, node, metastasis classification and beyond","volume":"27","author":"Kujala","year":"2013","journal-title":"Eye (Lond)"},{"key":"7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/eye.2012.255","article-title":"Molecular pathology of uveal melanoma","volume":"27","author":"Damato","year":"2013","journal-title":"Eye (Lond)"},{"key":"8","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0140-6736(96)90736-9","article-title":"Prognostic implications of monosomy 3 in uveal melanoma","volume":"347","author":"Becher","year":"1996","journal-title":"Lancet"},{"key":"9","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.ophtha.2007.06.012","article-title":"Cytogenetics of uveal melanoma: a 7-year clinical experience","volume":"114","author":"Howard","year":"2007","journal-title":"Ophthalmology"},{"key":"10","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/bjc.2015.269","article-title":"Upcoming translational challenges for uveal melanoma","volume":"113","author":"Sergio","year":"2015","journal-title":"Br J Cancer"},{"key":"11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/pcmr.12304","article-title":"Biology of advanced uveal melanoma and next steps for clinical therapeutics","volume":"28","author":"Sznol","year":"2015","journal-title":"Pigment Cell Melanoma Res"},{"key":"12","first-page":"1669","article-title":"Current and emerging treatment options for uveal melanoma","volume":"7","author":"Burnier","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000328333","article-title":"Therapeutic options in metastatic uveal melanoma","volume":"49","author":"Piperno-Neumann","year":"2012","journal-title":"Dev Ophthalmol"},{"key":"14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/pcmr.12433","article-title":"Insights into genetic alterations of liver metastases from uveal melanoma","volume":"29","author":"Coupland","year":"2016","journal-title":"Pigment Cell Melanoma Res"},{"key":"15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/bjophthalmol-2014-305371","article-title":"Uveal melanoma hepatic metastases mutation spectrum analysis using targeted next-generation sequencing of 400 cancer genes","volume":"99","author":"Pasmant","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"16","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1167\/iovs.08-2296","article-title":"Genomic profiling and identification of high-risk uveal melanoma by array CGH analysis of primary tumors, liver metastases","volume":"50","author":"Mariani","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"17","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1167\/iovs.07-0215","article-title":"Molecular characteristics of liver metastases from uveal melanoma","volume":"48","author":"Chowers","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"18","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.bbapap.2013.01.030","article-title":"Sieving through the cancer secretome","volume":"1834","author":"Chung","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"19","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.bbapap.2013.03.014","article-title":"The secretome in cancer progression","volume":"1834","author":"Khew-Goodall","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"20","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1021\/pr200344n","article-title":"Secretome compartment is a valuable source of biomarkers for cancer-relevant pathways","volume":"10","author":"Bongarzone","year":"2011","journal-title":"J Proteome Res"},{"key":"21","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.bbapap.2013.01.029","article-title":"The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context","volume":"1834","author":"Jimenez","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"22","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1021\/pr070021t","article-title":"Biomarker discovery from uveal melanoma secretomes: identification of gp100 and cathepsin D in patient serum","volume":"6","author":"Zitzmann","year":"2007","journal-title":"J Proteome Res"},{"key":"23","first-page":"1","article-title":"Cluster analysis of multiplex ligation-dependent probe amplification data in choroidal melanoma","volume":"21","author":"Taktak","year":"2015","journal-title":"Mol Vis"},{"key":"24","doi-asserted-by":"crossref","first-page":"8458","DOI":"10.1167\/iovs.11-7379","article-title":"Uveal melanoma cell lines contain stem-like cells that self-renew, produce differentiated progeny, and survive chemotherapy","volume":"52","author":"Coupland","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"25","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1167\/iovs.12-9584","article-title":"Comparison of formalin-fixed and snap-frozen samples analyzed by multiplex ligation-dependent probe amplification for prognostic testing in uveal melanoma","volume":"53","author":"Coupland","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"26","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1136\/bjophthalmol-2015-307057","article-title":"Concordant chromosome 3 results in paired choroidal melanoma biopsies and subsequent tumour resection specimens","volume":"99","author":"Heimann","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00417-006-0444-x","article-title":"The effect of ultraviolet radiation on choroidal melanocytes and melanoma cell lines: cell survival and matrix metalloproteinase production","volume":"245","author":"Madigan","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"28","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.jprot.2011.05.002","article-title":"Glioblastoma cell secretome: analysis of three glioblastoma cell lines reveal 148 non-redundant proteins","volume":"74","author":"Sirdeshmukh","year":"2011","journal-title":"J Proteomics"},{"key":"29","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1007\/s10886-007-9354-6","article-title":"Characterization of cauxin in the urine of domestic and big cats","volume":"33","author":"Beynon","year":"2007","journal-title":"J Chem Ecol"},{"key":"30","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1074\/mcp.M115.053488","article-title":"Proteome Dynamics: Tissue Variation in the Kinetics of Proteostasis in Intact Animals","volume":"15","author":"Beynon","year":"2016","journal-title":"Mol Cell Proteomics"},{"key":"31","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nmeth.1701","article-title":"SignalP 4. 0: discriminating signal peptides from transmembrane regions","volume":"8","author":"Nielsen","year":"2011","journal-title":"Nat Methods"},{"key":"32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/protein\/gzh037","article-title":"Feature-based prediction of non-classical and leaderless protein secretion","volume":"17","author":"Brunak","year":"2004","journal-title":"Protein Eng Des Sel"},{"key":"33","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1001\/archopht.1983.01040020896012","article-title":"A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma","volume":"101","author":"Robinson","year":"1983","journal-title":"Arch Ophthalmol"},{"key":"34","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1074\/mcp.M112.021618","article-title":"Unconventional secretion is a major contributor of cancer cell line secretomes","volume":"12","author":"Villanueva","year":"2013","journal-title":"Mol Cell Proteomics"},{"key":"35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1586\/14789450.4.2.273","article-title":"Proteomics in uveal melanoma research: opportunities and challenges in biomarker discovery","volume":"4","author":"Zitzmann","year":"2007","journal-title":"Expert Rev Proteomics"},{"issue":"53","key":"36","first-page":"4634","article-title":"Differential expression of fourteen proteins between uveal melanoma from patients who subsequently developed distant metastases versus those who did Not","volume":"9","author":"Meleady","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"37","doi-asserted-by":"crossref","first-page":"e0135543","DOI":"10.1371\/journal.pone.0135543","article-title":"iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors","volume":"10","author":"Singh","year":"2015","journal-title":"PLoS One"},{"key":"38","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1172\/JCI81135","article-title":"The biology and function of exosomes in cancer","volume":"126","author":"Kalluri","year":"2016","journal-title":"J Clin Invest"},{"key":"39","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1172\/JCI87316","article-title":"Extracellular vesicles: masters of intercellular communication and potential clinical interventions","volume":"126","author":"Zitvogel","year":"2016","journal-title":"J Clin Invest"},{"key":"40","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.24384","article-title":"Hepatic stellate cells: partners in crime for liver metastases?","volume":"54","author":"Shah","year":"2011","journal-title":"Hepatology"},{"key":"41","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nm.2753","article-title":"Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET","volume":"18","author":"Badal","year":"2012","journal-title":"Nat Med"},{"key":"42","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ncb3169","article-title":"Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver","volume":"17","author":"Theilen","year":"2015","journal-title":"Nat Cell Biol"},{"key":"43","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrc3726","article-title":"Hypoxia and the extracellular matrix: drivers of tumour metastasis","volume":"14","author":"Wirtz","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"44","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0014-5793(90)81009-D","article-title":"Degradation of type I and II collagen by human activated C1-s","volume":"268","author":"Sakiyama","year":"1990","journal-title":"FEBS Lett"},{"key":"45","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1242\/jcs.052761","article-title":"VAMP3, syntaxin-13 and SNAP23 are involved in secretion of matrix metalloproteinases, degradation of the extracellular matrix and cell invasion","volume":"122","author":"Coppolino","year":"2009","journal-title":"J Cell Sci"},{"key":"46","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/ijc.29820","article-title":"Myoferlin plays a key role in VEGFA secretion and impacts tumor-associated angiogenesis in human pancreas cancer","volume":"138","author":"Peulen","year":"2016","journal-title":"Int J Cancer"},{"key":"47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.vph.2011.04.001","article-title":"Myoferlin gene silencing decreases Tie-2 expressionand angiogenesis","volume":"55","author":"Bernatchez","year":"2011","journal-title":"Vascul Pharmacol"},{"key":"48","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1167\/iovs.05-0422","article-title":"Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study","volume":"47","author":"Pe'er","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"49","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00417-005-1171-4","article-title":"\u201cMelanoma inhibitory activity\u201d (MIA): a promising serological tumour marker in metastatic uveal melanoma","volume":"243","author":"Mueller","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"50","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/archopht.121.8.1117","article-title":"Prognostic value of S-100-beta serum concentration in patients with uveal melanoma","volume":"121","author":"Bonfrer","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"51","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00417-011-1786-6","article-title":"GDF-15: a novel serum marker for metastases in uveal melanoma patients","volume":"250","author":"Henke-Fahle","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"52","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1167\/iovs.11-7948","article-title":"Serum DJ-1\/PARK 7 is a potential biomarker of choroidal nevi transformation","volume":"53","author":"Pineiro","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"53","doi-asserted-by":"crossref","first-page":"7007","DOI":"10.1167\/iovs.15-17183","article-title":"ME20-S as a Potential Biomarker for the Evaluation of Uveal MelanomaME20-S as a Potential Biomarker to Evaluate UM","volume":"56","author":"Pardo","year":"2015","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"54","doi-asserted-by":"crossref","unstructured":"Barisione, Fabbi, Gino, Queirolo, Orgiano, Spano, Picasso, Pfeffer, Mosci, Jager, Ferrini, Gangemi. Potential Role of Soluble c-Met as a New Candidate Biomarker of Metastatic Uveal Melanoma. 2015; 133:1013\u201321. https:\/\/doi.org\/10.1001\/jamaophthalmol.2015.1766.","DOI":"10.1001\/jamaophthalmol.2015.1766"},{"key":"55","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1167\/iovs.12-10228","article-title":"Insulin-like growth factor-1 as a predictive biomarker for metastatic uveal melanoma in humans","volume":"54","author":"Barak","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"56","first-page":"3446","article-title":"Tissue and serum IGFBP7 protein as biomarker in high-grade soft tissue sarcoma","volume":"5","author":"Conti","year":"2015","journal-title":"Am J Cancer Res"},{"key":"57","first-page":"9","article-title":"Circulating Thrombospondin-2 and FGF-2 in Patients with Advanced Non-small Cell Lung Cancer: Correlation with Survival","volume":"833","author":"Niklinski","year":"2015","journal-title":"Adv Exp Med Biol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10418","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T19:52:12Z","timestamp":1656791532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,6]]},"references-count":57,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2016,8,2]]}},"alternative-id":["10418","27391064"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.10418","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,6]]}}}